Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

Mise à jour : Il y a 4 ans
Référence : NCT02279979

Femme et Homme

Extrait

The primary objective of this study is to assess reasonable safety and performance of the HeartMate PHP to provide hemodynamic support for up to 72 hours in patients with cardiogenic shock requiring stabilization.


Critère d'inclusion

  • Cardiogenic Shock


Liens